Glen; Angela

Patent Applications and Registrations

Patent applications and USPTO patent grants for Glen; Angela.The latest application filed is for "imidazo[1,2-b]pyridazine derivatives as trk inhibitors".

Company Profile

1.6.10

Glen; Angela - London GB
Glen; Angela - Cambridgeshire GB
Glen; Angela - Cambridge GB
Glen; Angela - Suffolk GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazo[1,2-b]pyridazine Derivatives As Trk Inhibitors App 20210277008 - Brown; Alan ; et al.	2021-09-09
Imidazo[1,2-b]pyridazines As Trk Inhibitors App 20210253572 - Brown; Alan ; et al.	2021-08-19
1,2-substituted cyclopentanes as orexin receptor antagonists Grant 10,689,373 - Fieldhouse , et al.	2020-06-23
1,2-substituted Cyclopentanes As Orexin Receptor Antagonists App 20180282309 - Fieldhouse; Charlotte ; et al.	2018-10-04
1,2-substituted cyclopentanes as orexin receptor antagonists Grant 10,011,588 - Fieldhouse , et al. July 3, 2	2018-07-03
Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists Grant 9,790,220 - Fieldhouse , et al. October 17, 2	2017-10-17
Substituted Cyclopentanes, Tetrahydrofuranes And Pyrrolidines As Orexin Receptor Antagonists App 20170073340 - Fieldhouse; Charlotte ; et al.	2017-03-16
1,2-substituted Cyclopentanes As Orexin Receptor Antagonists App 20170066744 - Fieldhouse; Charlotte ; et al.	2017-03-09
Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders Grant 9,493,432 - Fieldhouse , et al. November 15, 2	2016-11-15
Cyclopentylbenzamide Derivatives and their Use for the Treatment of Psychotic and Cognitive Disorders App 20160222030 - Fieldhouse; Charlotte ; et al.	2016-08-04
Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists Grant 9,156,829 - Fieldhouse , et al. October 13, 2	2015-10-13
Novel Compounds App 20150232460 - Fieldhouse; Charlotte ; et al.	2015-08-20
Pyrrolidine derivatives acting as CCR3-receptor antagonists Grant 7,754,758 - Bhalay , et al. July 13, 2	2010-07-13
Pyrrolidine Derivatives Acting As Ccr3-receptor Antagonists App 20090306138 - Bhalay; Gurdip ; et al.	2009-12-10
Heterocyclic Non-Peptide GNRH Antagonists App 20090209522 - Showell; Graham Andrew ; et al.	2009-08-20
Organic Compunds App 20080096943 - Bhalay; Gurdip ; et al.	2008-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.